Format

Send to

Choose Destination
See comment in PubMed Commons below
Cleve Clin J Med. 2012 Jul;79 Suppl 2:S30-4. doi: 10.3949/ccjm.79.s2a.06.

Comprehensive treatment of Huntington disease and other choreic disorders.

Author information

1
Center for Parkinson's Disease and Movement Disorders, Leonard M. Miller School of Medicine, University of Miami, Miami, FL 33136, USA. CSinger@med.miami.edu

Abstract

The management of choreic disorders presents significant challenges, including identifying the etiology of the disorder, treating and preventing motor symptoms, and managing a range of other neurologic and behavioral complications. Chorea may occur in several neurodegenerative, genetic, or drug-related conditions, and a thorough diagnostic evaluation is needed to identify the specific underlying causes. Some choreic disorders have specific treatable underlying etiologies, such as vitamin B(12) deficiency or drug-induced dyskinesia. Autoimmune disorders such as Sydenham chorea may be treated with penicillin, corticosteroids, intravenous immunoglobulin, or plasma exchange. Heredodegenerative choreas such as Huntington disease often respond to treatment with tetrabenazine or amantadine. Many other agents may be used nonspecifically for symptom control, including benzodiazepines, neuroleptics, and antiepileptic medications. In addition to motor symptoms, patients with Huntington disease or other choreic disorders often experience increasing depression, bradykinesia, cognitive impairment, aggressive behaviors, and other complications as the disease progresses. Caring for the caregiver is also a significant concern in the long-term treatment of choreic disorders.

PMID:
22761268
DOI:
10.3949/ccjm.79.s2a.06
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Cleveland Clinic
    Loading ...
    Support Center